An observational study in Gut Microbiota, Tip 2 Diabetes Mellitus and Food Literacy, sponsored by Istanbul Gedik University. Not yet recruiting. Open to male participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Istanbul Gedik University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This project is a two-phase, observational, cross-sectional study aiming to evaluate the relationships among food literacy, nutritional status, and gut microbiota profile in individuals with type 2 diabetes mellitus (T2DM).
In the first phase of the project, the questionnaire developed by Ludwig et al. (2024) for individuals with T2DM will be adapted into Turkish, and its validity and reliability will be evaluated. In the second phase, the study aims to determine the relationship between the level of food literacy and structural characteristics of the gut microbiota, such as microbial diversity and the Bacillota/Bacteroidota ratio. In addition, potential associations between biomarkers reflecting intestinal barrier integrity and food literacy will be investigated. Furthermore, the relationship between participants' nutritional status and gut microbiota profile will be assessed, differences in microbiota composition across different body mass index (BMI) categories will be examined, and the association between food literacy level and indicators of glycemic control will be determined.
The study will be conducted among volunteer individuals attending the Obesity and Diabetes Outpatient Clinic of the Department of Endocrinology and Metabolism, İstanbul University-Cerrahpaşa Faculty of Medicine. Sociodemographic information, 24-hour dietary records, anthropometric measurements, body composition, physical activity level, routine biochemical parameters, intestinal permeability biomarkers (LPS, zonulin, occludin, and claudin), and stool samples will be collected from the participants. Data collection will be conducted at a single time point, and the findings obtained will be analyzed using appropriate statistical methods.
The originality of the project lies in its holistic approach to food literacy in T2DM management by considering it together with gut microbiota and indicators of metabolic control. In addition, the Turkish adaptation of the food literacy scale developed specifically for individuals with T2DM will contribute to the literature by providing a valid and reliable measurement instrument that can be used in this field.
The findings of the study are expected to contribute to the development of evidence-based intervention programs targeting the behavioral and biological management of T2DM by elucidating the relationships among food literacy level, glycemic control, dietary patterns, and microbial diversity.
10,386 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,411 are open to participants now.
This study's planned enrollment of 60 is below the median of 300 across 1,744 observational studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →Istanbul Gedik University is the lead sponsor of 13 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Male aged 18-65 with type 2 diabetes
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
It is the only type of cross-sectional study that does not involve any intervention.
Food Literacy
The assessment is conducted using the Food Literacy Behaviors Questionnaire for Adults with Type 2 Diabetes (EFLBQ-DB), which has been adapted into Turkish and undergone validity and reliability analyses. The total score ranges from 21 to 84, with higher scores indicating higher levels of food literacy.
Time frame: 3 months
Gut microbiota profile
Assessment of gut microbiota composition and diversity using stool samples, including alpha and beta diversity indices, relative abundances of Bacillota and Bacteroidota, and the Bacillota/Bacteroidota ratio where applicable. Associations with food literacy behaviors and nutritional status will be examined. (16S rRNA)
Time frame: 3 months
Serum markers related to gut barrier function and microbial translocation
Serum lipopolysaccharide (LPS), zonulin, occludin, and claudin concentrations and their associations with gut microbiota, nutritional status, food literacy behaviors, and metabolic indicators.
Time frame: 3 months
Glycemic and metabolic indicators
Fasting blood glucose and fasting insulin concentrations; HOMA-IR may be calculated if appropriate.
Time frame: 3 months
Anthropometric measurements and body composition
Body Weight: Body weight will be measured in kilograms (kg). Height: Height will be measured in meters (m). Body Mass Index (BMI): BMI will be calculated as body weight (kg) divided by the square of height (m²) and reported in kg/m². Waist Circumference: Waist circumference will be measured in centimeters (cm). Hip Circumference: Hip circumference will be measured in centimeters (cm). Body Fat Percentage: Body fat percentage will be assessed and reported as a percentage (%). Muscle Mass: Muscle mass will be assessed and reported in kilograms (kg). Body Water Percentage: Body water percentage will be assessed and reported as a percentage (%).
Time frame: 3 months
Dietary intake
Energy and nutrient intake assessed using a 24-hour dietary recall, and their associations with food literacy behaviors, gut microbiota profile, and glycemic indicators.
Time frame: 3 months
Routine biochemical parameters
Albumin, total cholesterol, HDL-C, LDL-C, VLDL-C, triglycerides, blood urea, creatinine, uric acid, ALT, AST, GGT, and LDH.
Time frame: 3 months
Physical activity level
Assessment of physical activity using the International Physical Activity Questionnaire-Short Form (IPAQ-SF).
Time frame: 3 months
Sociodemographic and clinical characteristics
Assessment of participant characteristics and relevant clinical information using a structured participant information form. These variables will be used to describe the study population and identify potential confounders.
Time frame: 3 months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.
Of 434 non-industry observational studies under Diabetes Mellitus, Type 2, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 96. This study's planned 3 months is below that.
Counting every sponsor, half of 604 studies reached it within 32 months; a quarter within 17 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Gedik University